To reduce this risk it is common to use several different drugs together that are each aimed at different targets.
Doslej so razvili oziroma so v fazi razvoja proteazni zaviralci za naslednje virusne okužbe::* HIV/aids: protiretrovirusni zaviralci proteaz (sakvinavir, ritonavir, indinavir, nelfinavir, amprenavir etc.